Frank W. Rozsa

Frank W. Rozsa

Auto-generated profile, based on publicly available information

Frank W. Rozsa

Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI 48105

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2012 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
JWJaney L. Wiggs
Janey L. Wiggs
BYBrian L. Yaspan
Brian L. Yaspan
MHMichael A. Hauser
Michael A. Hauser
JKJae H. Kang
Jae H. Kang
RAR. Rand Allingham
R. Rand Allingham
JHJonathan L. Haines
Jonathan L. Haines
Optic nerve degeneration caused by glaucoma is a leading cause of blindness worldwide. Patients affected by the normal-pressure form of glaucoma are more likely to harbor risk alleles for glaucoma-related optic nerve disease. We have performed a meta-analysis of two independent genome-wide association studies for primary open angle glaucoma (POAG) followed by a normal-pressure glaucoma (NPG, defined by intraocular pressure (IOP) less than 22 mmHg) subgroup analysis. The single-nucleotide polymorphisms that showed the most significant associations were tested for association with a second form of glaucoma, exfoliation-syndrome glaucoma. The overall meta-analysis of the GLAUGEN and NEIGHBOR dataset results (3,146 cases and 3,487 controls) identified significant associations between two loci and POAG: the CDKN2BAS region on 9p21 (rs2157719 [G], OR = 0.69 [95%CI 0.63–0.75], p = 1.86×10−18), and the SIX1/SIX6 region on chromosome 14q23 (rs10483727 [A], OR = 1.32 [95%CI 1.21–1.43], p = 3.87×10−11). In sub-group analysis two loci were significantly associated with NPG: 9p21 containing the CDKN2BAS gene (rs2157719 [G], OR = 0.58 [95% CI 0.50–0.67], p = 1.17×10−12) and a probable regulatory region on 8q22 (rs284489 [G], OR = 0.62 [95% CI 0.53–0.72], p = 8.88×10−10). Both NPG loci were also nominally associated with a second type of glaucoma, exfoliation syndrome glaucoma (rs2157719 [G], OR = 0.59 [95% CI 0.41–0.87], p = 0.004 and rs284489 [G], OR = 0.76 [95% CI 0.54–1.06], p = 0.021), suggesting that these loci might contribute more generally to optic nerve degeneration in glaucoma. Because both loci influence transforming growth factor beta (TGF-beta) signaling, we performed a genomic pathway analysis that showed an association between the TGF-beta pathway and NPG (permuted p = 0.009). These results suggest that neuro-protective therapies targeting TGF-beta signaling could be effective for multiple forms of glaucoma. Loss of vision from glaucoma, a common cause of blindness worldwide, is due to irreversible damage to the optic nerve. Current therapies cannot prevent glaucoma-related optic nerve disease and very little is known about the underlying responsible molecular events. Glaucoma patients affected by the “normal-pressure” subtype of glaucoma (NPG) have increased susceptibility to optic nerve degeneration. Although NPG has a high heritability, common predisposing genetic variants have not been identified. Therefore, we performed a meta-analysis of two independent genome-wide association studies for a common form of glaucoma, primary open angle glaucoma (POAG), followed by NPG subgroup analysis. We found that SNPs in the CDKN2BAS gene region on 9p21 and a highly conserved region with a probable regulatory function on 8q22 were associated with NPG and with optic nerve disease in a second type of glaucoma, exfoliation glaucoma. Both genomic regions are predicted to influence TGF-beta activity, and using whole-genome data we showed that the TGF-beta signaling pathway overall is associated with NPG. These results reveal new insights into the molecular pathogenesis of optic nerve disease in glaucoma and are an important step toward the development of preventative and protective therapies.

1 November 2005 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CKCharles M. Krafchak
Charles M. Krafchak
HPHemant Pawar
Hemant Pawar
SMSayoko E. Moroi
Sayoko E. Moroi
ASAlan Sugar
Alan Sugar
PLPaul R. Lichter
Paul R. Lichter
JRJulia E. Richards
Julia E. Richards

1 August 2000 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
SSSatoko Shimizu
Satoko Shimizu
PLPaul R Lichter
Paul R Lichter
AJA.Tim Johnson
A.Tim Johnson
ZZZhaohui Zhou
Zhaohui Zhou
MHMisao Higashi
Misao Higashi
JRJulia E Richards
Julia E Richards

4 September 2013 in Human Genetics
Verified
Journal Article
Closed access
PDF file
NCNEIGHBOR Consortium
NEIGHBOR Consortium
AOA. Bilge Ozel
A. Bilge Ozel
SMSayoko E. Moroi
Sayoko E. Moroi
DRDavid M. Reed
David M. Reed
MNMelisa Nika
Melisa Nika
JLJun Z. Li
Jun Z. Li

1 January 1988 in Biochemistry
Verified
Journal Article
Closed access
CFCarol M. Foster
Carol M. Foster
JSJules A. Shafer
Jules A. Shafer
FRFrank W. Rozsa
Frank W. Rozsa
XWXueyan Wang
Xueyan Wang
SLSidney D. Lewis
Sidney D. Lewis
CCChristin Carter-Su
Christin Carter-Su

27 February 2006
Verified
Journal Article
Closed access
FRFrank W Rozsa
Frank W Rozsa
DRDavid M Reed
David M Reed
KSKathleen M Scott
Kathleen M Scott
HPHemant Pawar
Hemant Pawar
SMSayoko E Moroi
Sayoko E Moroi
JRJulia E Richards
Julia E Richards